Clearance Summary
EnSite Velocity Cardiac Mapping System v5.2 received FDA 510(k) clearance under submission number K172396, sponsored by St Jude Medical. The device was reviewed via the Traditional premarket notification pathway and assigned to the Cardiovascular review panel. The statutory decision date of record is 2018-04-23.
- Submission: K172396
- Applicant / Sponsor: St Jude Medical
- Clearance pathway: Traditional
- Review panel: Cardiovascular
- Device class: Class II
- Regulation citation: 21 CFR 870.1425
- Decision date: 2018-04-23
Classification & Regulation
This clearance is catalogued under FDA product code DQK and 21 CFR 870.1425, within the Cardiovascular review panel as a Class II device.